Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease
Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: V...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2018
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22717
- Acceso en línea:
- https://doi.org/10.1080/09273948.2017.1320411
https://repository.urosario.edu.co/handle/10336/22717
- Palabra clave:
- Cyclosporine
Dexamethasone
Folic acid
Methotrexate
Prednisone
Adult
Aged
Anterior eye chamber
Antiangiogenic activity
Arm
Article
B scan
Best corrected visual acuity
Bilateral iris depigmentation
Biomicroscopy
Case report
Cataract
Cataract extraction
Ciliary body
Clinical article
Clinical feature
Clinical outcome
Consultation
Cornea
Depigmentation
Diagnostic test
Disease duration
Disease severity
Drug dose escalation
Early diagnosis
Eye examination
Eye fundus
Eyelid
Female
Granulomatosis
Hand
Health service
Hospital admission
Human
Immunosuppressive treatment
Intraocular hypertension
Intraocular hypotension
Intraocular pressure
Iris atrophy
Iris disease
Lens implantation
Macular edema
Male
Medical history
Middle aged
Multiple cycle treatment
Neck
Optical coherence tomography
Patient referral
Pterygium
Recurrent disease
Retina detachment
Retina fluorescein angiography
Retina macula cystoid edema
Slit lamp microscopy
Transillumination
Treatment indication
Uveitis
Visual acuity
Vitiligo
Vitrectomy
Vitreous opacity
Vogt koyanagi syndrome
Atrophy
Hypopigmentation
Intraocular hypotension
Iris
Iris disease
Meningoencephalitis
Pathology
Pigment epithelium
Slit lamp
Adult
Aged
Atrophy
Female
Humans
Hypopigmentation
Iris
Iris diseases
Male
Middle aged
Ocular hypotension
Pigment epithelium of eye
Slit lamp
Uveomeningoencephalitic syndrome
Iris atrophy
Iris depigmentation
Ocular hypotony
Panuveitis
Vkh
Vogt–koyanagi–harada disease
optical coherence
Tomography
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_5aa448b54e3f23175edba31923ee3d46 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/22717 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
075cd1f5-fe86-43f9-a84c-1c1bc5c10bd85170135560075481961-d9f8-49a2-9cbb-91c08a431bd92020-05-25T23:57:40Z2020-05-25T23:57:40Z2018Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: Vogt–Koyanagi–Harada disease in late recurrent stage was diagnosed in three patients with bilateral severe iris depigmentation and persistent ocular hypotony. Conclusions: Early diagnosis and treatment of inflammation are crucial factors in the clinical outcome of Vogt–Koyanagi–Harada disease. When left undiagnosed and untreated from early stages, severe iris depigmentation and ocular hypotony, uncommon manifestations of this disease, can develop. ©, © Taylor and Francis Group, LLC.application/pdfhttps://doi.org/10.1080/09273948.2017.13204119273948https://repository.urosario.edu.co/handle/10336/22717engTaylor and Francis Ltd1106No. 71101Ocular Immunology and InflammationVol. 26Ocular Immunology and Inflammation, ISSN:9273948, Vol.26, No.7 (2018); pp. 1101-1106https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019707641&doi=10.1080%2f09273948.2017.1320411&partnerID=40&md5=006a9f59c57db046fdb6b370caf7af91Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURCyclosporineDexamethasoneFolic acidMethotrexatePrednisoneAdultAgedAnterior eye chamberAntiangiogenic activityArmArticleB scanBest corrected visual acuityBilateral iris depigmentationBiomicroscopyCase reportCataractCataract extractionCiliary bodyClinical articleClinical featureClinical outcomeConsultationCorneaDepigmentationDiagnostic testDisease durationDisease severityDrug dose escalationEarly diagnosisEye examinationEye fundusEyelidFemaleGranulomatosisHandHealth serviceHospital admissionHumanImmunosuppressive treatmentIntraocular hypertensionIntraocular hypotensionIntraocular pressureIris atrophyIris diseaseLens implantationMacular edemaMaleMedical historyMiddle agedMultiple cycle treatmentNeckOptical coherence tomographyPatient referralPterygiumRecurrent diseaseRetina detachmentRetina fluorescein angiographyRetina macula cystoid edemaSlit lamp microscopyTransilluminationTreatment indicationUveitisVisual acuityVitiligoVitrectomyVitreous opacityVogt koyanagi syndromeAtrophyHypopigmentationIntraocular hypotensionIrisIris diseaseMeningoencephalitisPathologyPigment epitheliumSlit lampAdultAgedAtrophyFemaleHumansHypopigmentationIrisIris diseasesMaleMiddle agedOcular hypotensionPigment epithelium of eyeSlit lampUveomeningoencephalitic syndromeIris atrophyIris depigmentationOcular hypotonyPanuveitisVkhVogt–koyanagi–harada diseaseoptical coherenceTomographyBilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada DiseasearticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Cuevas M.de-la-Torre, AlejandraCórdoba A.10336/22717oai:repository.urosario.edu.co:10336/227172022-05-02 07:37:15.943908https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease |
title |
Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease |
spellingShingle |
Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease Cyclosporine Dexamethasone Folic acid Methotrexate Prednisone Adult Aged Anterior eye chamber Antiangiogenic activity Arm Article B scan Best corrected visual acuity Bilateral iris depigmentation Biomicroscopy Case report Cataract Cataract extraction Ciliary body Clinical article Clinical feature Clinical outcome Consultation Cornea Depigmentation Diagnostic test Disease duration Disease severity Drug dose escalation Early diagnosis Eye examination Eye fundus Eyelid Female Granulomatosis Hand Health service Hospital admission Human Immunosuppressive treatment Intraocular hypertension Intraocular hypotension Intraocular pressure Iris atrophy Iris disease Lens implantation Macular edema Male Medical history Middle aged Multiple cycle treatment Neck Optical coherence tomography Patient referral Pterygium Recurrent disease Retina detachment Retina fluorescein angiography Retina macula cystoid edema Slit lamp microscopy Transillumination Treatment indication Uveitis Visual acuity Vitiligo Vitrectomy Vitreous opacity Vogt koyanagi syndrome Atrophy Hypopigmentation Intraocular hypotension Iris Iris disease Meningoencephalitis Pathology Pigment epithelium Slit lamp Adult Aged Atrophy Female Humans Hypopigmentation Iris Iris diseases Male Middle aged Ocular hypotension Pigment epithelium of eye Slit lamp Uveomeningoencephalitic syndrome Iris atrophy Iris depigmentation Ocular hypotony Panuveitis Vkh Vogt–koyanagi–harada disease optical coherence Tomography |
title_short |
Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease |
title_full |
Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease |
title_fullStr |
Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease |
title_full_unstemmed |
Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease |
title_sort |
Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease |
dc.subject.keyword.spa.fl_str_mv |
Cyclosporine Dexamethasone Folic acid Methotrexate Prednisone Adult Aged Anterior eye chamber Antiangiogenic activity Arm Article B scan Best corrected visual acuity Bilateral iris depigmentation Biomicroscopy Case report Cataract Cataract extraction Ciliary body Clinical article Clinical feature Clinical outcome Consultation Cornea Depigmentation Diagnostic test Disease duration Disease severity Drug dose escalation Early diagnosis Eye examination Eye fundus Eyelid Female Granulomatosis Hand Health service Hospital admission Human Immunosuppressive treatment Intraocular hypertension Intraocular hypotension Intraocular pressure Iris atrophy Iris disease Lens implantation Macular edema Male Medical history Middle aged Multiple cycle treatment Neck Optical coherence tomography Patient referral Pterygium Recurrent disease Retina detachment Retina fluorescein angiography Retina macula cystoid edema Slit lamp microscopy Transillumination Treatment indication Uveitis Visual acuity Vitiligo Vitrectomy Vitreous opacity Vogt koyanagi syndrome Atrophy Hypopigmentation Intraocular hypotension Iris Iris disease Meningoencephalitis Pathology Pigment epithelium Slit lamp Adult Aged Atrophy Female Humans Hypopigmentation Iris Iris diseases Male Middle aged Ocular hypotension Pigment epithelium of eye Slit lamp Uveomeningoencephalitic syndrome Iris atrophy Iris depigmentation Ocular hypotony Panuveitis Vkh Vogt–koyanagi–harada disease |
topic |
Cyclosporine Dexamethasone Folic acid Methotrexate Prednisone Adult Aged Anterior eye chamber Antiangiogenic activity Arm Article B scan Best corrected visual acuity Bilateral iris depigmentation Biomicroscopy Case report Cataract Cataract extraction Ciliary body Clinical article Clinical feature Clinical outcome Consultation Cornea Depigmentation Diagnostic test Disease duration Disease severity Drug dose escalation Early diagnosis Eye examination Eye fundus Eyelid Female Granulomatosis Hand Health service Hospital admission Human Immunosuppressive treatment Intraocular hypertension Intraocular hypotension Intraocular pressure Iris atrophy Iris disease Lens implantation Macular edema Male Medical history Middle aged Multiple cycle treatment Neck Optical coherence tomography Patient referral Pterygium Recurrent disease Retina detachment Retina fluorescein angiography Retina macula cystoid edema Slit lamp microscopy Transillumination Treatment indication Uveitis Visual acuity Vitiligo Vitrectomy Vitreous opacity Vogt koyanagi syndrome Atrophy Hypopigmentation Intraocular hypotension Iris Iris disease Meningoencephalitis Pathology Pigment epithelium Slit lamp Adult Aged Atrophy Female Humans Hypopigmentation Iris Iris diseases Male Middle aged Ocular hypotension Pigment epithelium of eye Slit lamp Uveomeningoencephalitic syndrome Iris atrophy Iris depigmentation Ocular hypotony Panuveitis Vkh Vogt–koyanagi–harada disease optical coherence Tomography |
dc.subject.keyword.eng.fl_str_mv |
optical coherence Tomography |
description |
Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: Vogt–Koyanagi–Harada disease in late recurrent stage was diagnosed in three patients with bilateral severe iris depigmentation and persistent ocular hypotony. Conclusions: Early diagnosis and treatment of inflammation are crucial factors in the clinical outcome of Vogt–Koyanagi–Harada disease. When left undiagnosed and untreated from early stages, severe iris depigmentation and ocular hypotony, uncommon manifestations of this disease, can develop. ©, © Taylor and Francis Group, LLC. |
publishDate |
2018 |
dc.date.created.spa.fl_str_mv |
2018 |
dc.date.accessioned.none.fl_str_mv |
2020-05-25T23:57:40Z |
dc.date.available.none.fl_str_mv |
2020-05-25T23:57:40Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1080/09273948.2017.1320411 |
dc.identifier.issn.none.fl_str_mv |
9273948 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/22717 |
url |
https://doi.org/10.1080/09273948.2017.1320411 https://repository.urosario.edu.co/handle/10336/22717 |
identifier_str_mv |
9273948 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
1106 |
dc.relation.citationIssue.none.fl_str_mv |
No. 7 |
dc.relation.citationStartPage.none.fl_str_mv |
1101 |
dc.relation.citationTitle.none.fl_str_mv |
Ocular Immunology and Inflammation |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 26 |
dc.relation.ispartof.spa.fl_str_mv |
Ocular Immunology and Inflammation, ISSN:9273948, Vol.26, No.7 (2018); pp. 1101-1106 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019707641&doi=10.1080%2f09273948.2017.1320411&partnerID=40&md5=006a9f59c57db046fdb6b370caf7af91 |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Taylor and Francis Ltd |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167590678822912 |